×
S&P 500   3,816.84 (-0.12%)
DOW   31,012.17 (+0.21%)
QQQ   283.99 (+0.16%)
AAPL   140.16 (+1.98%)
MSFT   261.53 (+1.97%)
META   163.77 (+1.92%)
GOOGL   2,242.01 (+0.08%)
AMZN   109.48 (+1.94%)
TSLA   674.88 (-3.31%)
NVDA   155.42 (-2.75%)
NIO   21.61 (-3.35%)
BABA   115.74 (-0.87%)
AMD   77.48 (-4.09%)
MU   56.15 (-2.96%)
CGC   3.53 (-2.22%)
T   20.73 (+0.58%)
GE   64.06 (-2.76%)
F   11.53 (-2.37%)
DIS   95.02 (-0.94%)
AMC   13.29 (-0.67%)
PFE   51.18 (+1.03%)
PYPL   71.49 (-0.46%)
NFLX   176.61 (-1.66%)
S&P 500   3,816.84 (-0.12%)
DOW   31,012.17 (+0.21%)
QQQ   283.99 (+0.16%)
AAPL   140.16 (+1.98%)
MSFT   261.53 (+1.97%)
META   163.77 (+1.92%)
GOOGL   2,242.01 (+0.08%)
AMZN   109.48 (+1.94%)
TSLA   674.88 (-3.31%)
NVDA   155.42 (-2.75%)
NIO   21.61 (-3.35%)
BABA   115.74 (-0.87%)
AMD   77.48 (-4.09%)
MU   56.15 (-2.96%)
CGC   3.53 (-2.22%)
T   20.73 (+0.58%)
GE   64.06 (-2.76%)
F   11.53 (-2.37%)
DIS   95.02 (-0.94%)
AMC   13.29 (-0.67%)
PFE   51.18 (+1.03%)
PYPL   71.49 (-0.46%)
NFLX   176.61 (-1.66%)
S&P 500   3,816.84 (-0.12%)
DOW   31,012.17 (+0.21%)
QQQ   283.99 (+0.16%)
AAPL   140.16 (+1.98%)
MSFT   261.53 (+1.97%)
META   163.77 (+1.92%)
GOOGL   2,242.01 (+0.08%)
AMZN   109.48 (+1.94%)
TSLA   674.88 (-3.31%)
NVDA   155.42 (-2.75%)
NIO   21.61 (-3.35%)
BABA   115.74 (-0.87%)
AMD   77.48 (-4.09%)
MU   56.15 (-2.96%)
CGC   3.53 (-2.22%)
T   20.73 (+0.58%)
GE   64.06 (-2.76%)
F   11.53 (-2.37%)
DIS   95.02 (-0.94%)
AMC   13.29 (-0.67%)
PFE   51.18 (+1.03%)
PYPL   71.49 (-0.46%)
NFLX   176.61 (-1.66%)
S&P 500   3,816.84 (-0.12%)
DOW   31,012.17 (+0.21%)
QQQ   283.99 (+0.16%)
AAPL   140.16 (+1.98%)
MSFT   261.53 (+1.97%)
META   163.77 (+1.92%)
GOOGL   2,242.01 (+0.08%)
AMZN   109.48 (+1.94%)
TSLA   674.88 (-3.31%)
NVDA   155.42 (-2.75%)
NIO   21.61 (-3.35%)
BABA   115.74 (-0.87%)
AMD   77.48 (-4.09%)
MU   56.15 (-2.96%)
CGC   3.53 (-2.22%)
T   20.73 (+0.58%)
GE   64.06 (-2.76%)
F   11.53 (-2.37%)
DIS   95.02 (-0.94%)
AMC   13.29 (-0.67%)
PFE   51.18 (+1.03%)
PYPL   71.49 (-0.46%)
NFLX   176.61 (-1.66%)

Cabot Stock Forecast, Price & News

$63.43
-1.43 (-2.20%)
(As of 06/29/2022 11:37 AM ET)
Add
Compare
Today's Range
$63.09
$64.35
50-Day Range
$60.56
$78.03
52-Week Range
$47.59
$78.62
Volume
2,830 shs
Average Volume
468,616 shs
Market Capitalization
$3.58 billion
P/E Ratio
28.19
Dividend Yield
2.25%
Price Target
$75.67
30 days | 90 days | 365 days | Advanced Chart

Receive CBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cabot and its competitors with MarketBeat's FREE daily newsletter.

CBT Stock Forecast (MarketRank)

Overall MarketRank

2.68 out of 5 stars

Basic Materials Sector

53rd out of 248 stocks

Miscellaneous Chemical Products Industry

2nd out of 11 stocks

Analyst Opinion: 2.4Community Rank: 4.1Dividend Strength: 2.5Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -
Cabot logo

About Cabot (NYSE:CBT)

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty carbons used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.

CBT Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Miscellaneous chemical products
Sub-Industry
Commodity Chemicals
CUSIP
12705510
Employees
4,500
Year Founded
N/A

Company Calendar

Last Earnings
5/02/2022
Ex-Dividend for 6/10 Dividend
5/26/2022
Dividend Payable
6/10/2022
Today
6/29/2022
Next Earnings (Estimated)
8/08/2022
Fiscal Year End
9/30/2022

Price Target and Rating

Average Stock Price Forecast
$75.67
High Stock Price Forecast
$86.00
Low Stock Price Forecast
$62.00
Forecasted Upside/Downside
+19.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83333333333333
Research Coverage
6 Analysts

Profitability

Net Income
$250 million
Pretax Margin
6.26%

Debt

Sales & Book Value

Annual Sales
$3.41 billion
Cash Flow
$7.69 per share
Book Value
$19.22 per share

Miscellaneous

Free Float
55,192,000
Market Cap
$3.58 billion
Optionable
Optionable
Beta
1.36














Cabot Frequently Asked Questions

Should I buy or sell Cabot stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" Cabot stock.
View analyst ratings for Cabot
or view top-rated stocks.

What is Cabot's stock price forecast for 2022?

6 analysts have issued 12 month price targets for Cabot's stock. Their CBT stock forecasts range from $62.00 to $86.00. On average, they predict Cabot's stock price to reach $75.67 in the next year. This suggests a possible upside of 19.3% from the stock's current price.
View analysts' price targets for Cabot
or view top-rated stocks among Wall Street analysts.

How has Cabot's stock price performed in 2022?

Cabot's stock was trading at $56.20 at the start of the year. Since then, CBT shares have increased by 12.9% and is now trading at $63.43.
View the best growth stocks for 2022 here
.

Are investors shorting Cabot?

Cabot saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 1,990,000 shares, an increase of 25.2% from the May 31st total of 1,590,000 shares. Based on an average daily trading volume, of 442,900 shares, the short-interest ratio is presently 4.5 days.
View Cabot's Short Interest
.

When is Cabot's next earnings date?

Cabot is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Cabot
.

How were Cabot's earnings last quarter?

Cabot Co. (NYSE:CBT) announced its quarterly earnings data on Monday, May, 2nd. The specialty chemicals company reported $1.69 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.29. The specialty chemicals company had revenue of $1.09 billion for the quarter, compared to analysts' expectations of $918.99 million. Cabot had a trailing twelve-month return on equity of 29.91% and a net margin of 3.43%. During the same quarter in the prior year, the business earned $1.38 earnings per share.
View Cabot's earnings history
.

How often does Cabot pay dividends? What is the dividend yield for Cabot?

Cabot announced a quarterly dividend on Friday, May 13th. Stockholders of record on Friday, May 27th will be paid a dividend of $0.37 per share on Friday, June 10th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 2.33%. The ex-dividend date of this dividend is Thursday, May 26th.
View Cabot's dividend history
.

Is Cabot a good dividend stock?

Cabot(NYSE:CBT) pays an annual dividend of $1.48 per share and currently has a dividend yield of 2.25%. Cabot does not yet have a strong track record of dividend growth. The dividend payout ratio of Cabot is 65.78%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cabot will have a dividend payout ratio of 19.53% next year. This indicates that Cabot will be able to sustain or increase its dividend.
View Cabot's dividend history.

What guidance has Cabot issued on next quarter's earnings?

Cabot updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $5.80-$6.20 for the period, compared to the consensus estimate of $5.80. The company issued revenue guidance of -.

Who are Cabot's key executives?

Cabot's management team includes the following people:
  • Mr. Sean D. Keohane, Pres, CEO & Director (Age 55, Pay $3.48M)
  • Ms. Erica J. McLaughlin, Sr. VP & CFO (Age 45, Pay $1.33M)
  • Ms. Karen A. Kalita, Sr. VP & Gen. Counsel (Age 42, Pay $970.77k) (LinkedIn Profile)
  • Mr. Jeff Ji Zhu, Sr. VP, Pres of Performance Additives Bus. & Pres of Asia Pacific Region (Age 53, Pay $2.06M)
  • Mr. Hobart C. Kalkstein, Sr. VP, Pres of Reinforcement Materials Segment & Pres of Americas Region (Age 52, Pay $1.21M)
  • Ms. Patricia Hubbard, Sr. VP & CTO
  • Mr. Steven J. Delahunt, VP of Investor Relations & Treasurer
  • Ms. Vanessa Craigie, Corp. Communications Director
  • Mr. Arthur T. Wood, Sr. VP & Chief HR Officer
  • Mr. Martin J. O'Neill, Sr. VP of Safety, Health and Environment & Chief Sustainability Officer

What is Sean Keohane's approval rating as Cabot's CEO?

40 employees have rated Cabot CEO Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among Cabot's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Cabot's key competitors?

What other stocks do shareholders of Cabot own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

What is Cabot's stock symbol?

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Who are Cabot's major shareholders?

Cabot's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.25%), Vanguard Group Inc. (10.85%), Wellington Management Group LLP (6.28%), Earnest Partners LLC (5.39%), Fuller & Thaler Asset Management Inc. (4.74%) and LSV Asset Management (3.43%). Company insiders that own Cabot stock include Hobart Kalkstein, Karen A Kalita, Karen A Kalita, Sean D Keohane and Sean D Keohane.
View institutional ownership trends for Cabot
.

Which major investors are selling Cabot stock?

CBT stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Fuller & Thaler Asset Management Inc., LSV Asset Management, Russell Investments Group Ltd., Royal Bank of Canada, Foundry Partners LLC, Prudential Financial Inc., and Strs Ohio. Company insiders that have sold Cabot company stock in the last two years include Hobart Kalkstein, Karen A Kalita, and Sean D Keohane.
View insider buying and selling activity for Cabot
or view top insider-selling stocks.

Which major investors are buying Cabot stock?

CBT stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., GMT Capital Corp, Vanguard Group Inc., Wellington Management Group LLP, Invesco Ltd., Lombard Odier Asset Management Europe Ltd, Leeward Investments LLC MA, and Boston Partners.
View insider buying and selling activity for Cabot
or or view top insider-buying stocks.

How do I buy shares of Cabot?

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cabot's stock price today?

One share of CBT stock can currently be purchased for approximately $63.43.

How much money does Cabot make?

Cabot (NYSE:CBT) has a market capitalization of $3.58 billion and generates $3.41 billion in revenue each year. The specialty chemicals company earns $250 million in net income (profit) each year or $2.25 on an earnings per share basis.

How many employees does Cabot have?

Cabot employs 4,500 workers across the globe.

How can I contact Cabot?

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The official website for Cabot is www.cabot-corp.com. The specialty chemicals company can be reached via phone at (617) 345-0100, via email at [email protected], or via fax at 617-342-6103.

This page (NYSE:CBT) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.